Our Experience

Three pills and three groups of people representing trials

>35 IND - CTA

4 Phase 3 (US, EU, Asia)

A magnified glass directed to package with a medication representing drug discovery

2 new drug

applications

Collection of books

80 domain

specific publications

Meet our team

Drug Development Unit (DDU)

DDU validates drug candidates and patient subgroups for neuropsychiatric and neurodevelopmental disorders through observational studies and investigational trials. DDU combines expertise in operations, medicine, drug and clinical development, to bring STALICLA’s clinical-stage treatment options closer to patients.

Discovery and Data Science Unit (DDS)

DDS applies AI-driven and systems biology precision medicine approaches to patient data sets. Bringing together computational biologists, human geneticists, data scientists, chemo-informaticians and developers, DDS ensures that STALICLA’s first-in-class DEPI technology is producing next-generation therapeutics for NDDs.